N-[(2-Chlorophenyl)sulfonyl]-7-({[(2-chlorophenyl)sulfonyl]carbamoyl}amino)-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxamide

ID: ALA3917835

Chembl Id: CHEMBL3917835

PubChem CID: 24803631

Max Phase: Preclinical

Molecular Formula: C24H22Cl2N4O6S2

Molecular Weight: 597.50

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc2c(c1)CCN(C(=O)NS(=O)(=O)c1ccccc1Cl)CC2)NS(=O)(=O)c1ccccc1Cl

Standard InChI:  InChI=1S/C24H22Cl2N4O6S2/c25-19-5-1-3-7-21(19)37(33,34)28-23(31)27-18-10-9-16-11-13-30(14-12-17(16)15-18)24(32)29-38(35,36)22-8-4-2-6-20(22)26/h1-10,15H,11-14H2,(H,29,32)(H2,27,28,31)

Standard InChI Key:  PAVKVAVLFSSLRE-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3917835

   n-[(2-Chlorophenyl)sulfonyl]-7-({[(2-chlorophenyl)sulfonyl]carbamoyl}amino)-1,2,4,5-tetrahydro-3h-3-benzazepine-3-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 597.50

Molecular Weight (Monoisotopic): 596.0358

AlogP: 4.00

#Rotatable Bonds: 5

Polar Surface Area: 141.75

Molecular Species: ACID

HBA: 6

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 2.46

CX Basic pKa:

CX LogP: 4.45

CX LogD: 2.56

Aromatic Rings: 3

Heavy Atoms: 38

QED Weighted: 0.41

Np Likeness Score: -1.29

References

1.  (2009)  Ion channel modulators and uses thereof, 

Source

Source(1):

• Patent Bioactivity Data